Related references
Note: Only part of the references are listed.Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2
Dieter Waschbusch et al.
STRUCTURE (2020)
PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at Threonine72
Sophie Vieweg et al.
BIOCHEMICAL JOURNAL (2020)
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
Marco A. S. Baptista et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
LRRK2 activation controls the repair of damaged endomembranes in macrophages
Susanne Herbst et al.
EMBO JOURNAL (2020)
PINOT: an intuitive resource for integrating protein-protein interactions
James E. Tomkins et al.
CELL COMMUNICATION AND SIGNALING (2020)
LRRK2 mediates tubulation and vesicle sorting from lysosomes
Luis Bonet-Ponce et al.
SCIENCE ADVANCES (2020)
Caught in the act: LRRK2 in exosomes
Shijie Wang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans
Dieter Lang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2019)
LRRK2 regulation of immune-pathways and inflammatory disease
Rebecca L. Wallings et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins
Kerryn Berndsen et al.
ELIFE (2019)
Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice
Laura Pellegrini et al.
HUMAN MOLECULAR GENETICS (2018)
LRRK2 kinase in Parkinson's disease
Dario R. Alessi et al.
SCIENCE (2018)
PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats
Michael Aagaard Andersen et al.
TOXICOLOGY (2018)
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
MARCKS and MARCKS-like proteins in development and regeneration
Mohamed El Amri et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
Jillian H. Kluss et al.
NPJ PARKINSONS DISEASE (2018)
Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
Pawel Lis et al.
BIOCHEMICAL JOURNAL (2018)
Rab29 activation of the Parkinson's disease-associated LRRK2 kinase
Elena Purlyte et al.
EMBO JOURNAL (2018)
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
Andrew B. West
EXPERIMENTAL NEUROLOGY (2017)
LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease
Evan H. Howlett et al.
HUMAN MOLECULAR GENETICS (2017)
Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease
Kyle B. Fraser et al.
MOVEMENT DISORDERS (2016)
Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
E. Lobbestael et al.
SCIENTIFIC REPORTS (2016)
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
Joao P. L. Daher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors
Anthony A. Estrada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
Reina N. Fuji et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibitions
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
LRRK2, but not pathogenic mutants, protects against H2O2 stress depending on mitochondrial function and endocytosis in a yeast model
Clara Pereira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
MARCKS regulates membrane targeting of Rab10 vesicles to promote axon development
Xiao-Hui Xu et al.
CELL RESEARCH (2014)
Arsenite Stress Down-regulates Phosphorylation and 14-3-3 Binding of Leucine-rich Repeat Kinase 2 (LRRK2), Promoting Self-association and Cellular Redistribution
Adamantios Mamais et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction
Laurie H. Sanders et al.
NEUROBIOLOGY OF DISEASE (2014)
Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications
Iakov N. Rudenko et al.
NEUROTHERAPEUTICS (2014)
Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases
Adamantios Mamais et al.
NEUROBIOLOGY OF DISEASE (2013)
Lysosomal Membrane Proteins and Their Central Role in Physiology
Michael Schwake et al.
TRAFFIC (2013)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
Heather Mortiboys et al.
NEUROLOGY (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
Louis J. Sparvero et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
g:Profiler -: a web-based toolset for functional profiling of gene lists from large-scale experiments
Jueri Reimand et al.
NUCLEIC ACIDS RESEARCH (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Share Paper
